Does LSD Have Any Therapeutical Value In Mental Disorders? A Non-Systemic Review
Introduction Lysergic acid diethylamide (LSD) a semi synthetic hallucinogen, was first synthetized by Albert Hofmann in 1938 and its psychological properties were not discovered until 1943. There was a brief renaissance of its use in psychiatry, specifically in assisted psychotherapy for the treatm...
Main Authors: | L. Silva, L. Bravo |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2022-06-01
|
Series: | European Psychiatry |
Subjects: | |
Online Access: | https://www.cambridge.org/core/product/identifier/S0924933822022726/type/journal_article |
Similar Items
-
Therapeutic use of psychedelic drugs in depression disorders
by: M. Trigo
Published: (2021-04-01) -
Marginalisation, stigmatisation et abandon du LSD en médecine
by: Zoë Dubus
Published: (2020-11-01) -
LSD and psilocybin for chronic nociplastic pain: A narrative review of the literature supporting the use of classic psychedelic agents in chronic pain
by: J Van Der Walt, et al.
Published: (2023-11-01) -
LSD-induced changes in the functional connectivity of distinct thalamic nuclei
by: Stefano Delli Pizzi, et al.
Published: (2023-12-01) -
Psychedelics and psychiatric disorders: A emerging role
by: C. Peixoto, et al.
Published: (2021-04-01)